Literature DB >> 15983426

Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia.

Jurgen Thiele1, Hans Michael Kvasnicka, Volker Diehl.   

Abstract

Patients have previously been described who showed clinical signs and symptoms suggesting essential thrombocythemia (ET), but later transformed to polycythemia vera (PV). From a series of 344 patients with a sustained borderline to moderate erythrocytosis, 44 failed to conform initially with the diagnostic criteria of the WHO for PV, because of their low hemoglobin level. Twenty-three patients of this group presented with a thrombocytosis exceeding 600 x 10(9)/l and therefore suggested ET, but later developed full-blown PV. For comparison we investigated also 164 patients with manifest PV, 90 patients with ET and 22 patients with reactive thrombocytosis (Th). The histopathology of initial PV was evaluated by stepwise discriminant analysis of 17 standardized features. Quantity and left shifting of erythro- and granulopoiesis, giant forms and naked nuclei of megakaryocytes, cellularity and reticulin fibers proved to exert a significant relevance concerning differentiation from true ET and Th. In conclusion, initial PV with thrombocytosis is characterized by a special pattern of BM histopathology. Therefore, so-called masked PV in patients with ET or simultaneous PVR-1 gene expression and endogeneous erythroid colony growth in ET patients are probably in keeping with initial PV mimicking ET. Copyright (c) 2005 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2005        PMID: 15983426     DOI: 10.1159/000084673

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  13 in total

1.  European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360-5--comment.

Authors:  Jürgen Thiele; Attilio Orazi; Hans Michael Kvasnicka; Vito Franco; Emanuela Boveri; Umberto Gianelli; Heinz Gisslinger; Francesco Passamonti; Ayalew Tefferi; Tiziano Barbui
Journal:  Haematologica       Date:  2012-03       Impact factor: 9.941

Review 2.  WHO classification of myeloproliferative neoplasms (MPN): A critical update.

Authors:  Hans Michael Kvasnicka
Journal:  Curr Hematol Malig Rep       Date:  2013-12       Impact factor: 3.952

3.  Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses.

Authors:  Nabih Maslah; Juliette Soret; Christine Dosquet; Laetitia Vercellino; Célia Belkhodja; Marie-Hélène Schlageter; Bruno Cassinat; Jean-Jacques Kiladjian; Christine Chomienne; Stephane Giraudier
Journal:  Haematologica       Date:  2019-08-14       Impact factor: 9.941

4.  Essential thrombocythemia with high hemoglobin levels according to the revised WHO classification.

Authors:  T Barbui; J Thiele; H M Kvasnicka; A Carobbio; A M Vannucchi; A Tefferi
Journal:  Leukemia       Date:  2014-06-03       Impact factor: 11.528

Review 5.  Rethinking the diagnostic criteria of polycythemia vera.

Authors:  T Barbui; J Thiele; A M Vannucchi; A Tefferi
Journal:  Leukemia       Date:  2013-12-19       Impact factor: 11.528

6.  Time for revival of the red blood cell count and red cell mass in the differential diagnosis between essential thrombocythemia and polycythemia vera?

Authors:  Hans Carl Hasselbalch
Journal:  Haematologica       Date:  2019-11       Impact factor: 9.941

7.  The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis.

Authors:  Juergen Thiele; Hans Michael Kvasnicka
Journal:  Curr Hematol Malig Rep       Date:  2009-01       Impact factor: 3.952

Review 8.  Is it justified to perform a bone marrow biopsy examination in sustained erythrocytosis?

Authors:  Juergen Thiele; Hans Michael Kvasnicka
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

9.  Diagnostic usefulness of the Janus kinase 2 mutation in non BCR/ABL myeloproliferative disorders.

Authors:  Soo-Mee Bang; Jeong Yeal Ahn; Jiyoon Park; Soo Jin Yoo; Se Hoon Park; Eun Mi Nam; Pil Whan Park; Yiel Hea Seo; Eun Kyung Cho; Dong Bok Shin; Jae Hoon Lee
Journal:  Korean J Intern Med       Date:  2006-12       Impact factor: 2.884

Review 10.  Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.

Authors:  T Barbui; J Thiele; A M Vannucchi; A Tefferi
Journal:  Blood Cancer J       Date:  2015-08-14       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.